63540 Federal Register / Vol. 69, No. 211 / Tuesday, November 2, 2004 / Notices 

SUMMARY: The Administration on Aging 

will accept applications for funding for 

a three-year project period, April 1, 

2005, to March 31, 2008, in FY 2005 

under the OAA, title VI, part A, Grants 

for Native Americans and title VI, part 

C, Grants for the Native American 

Caregiver Support Program. Current 

funding levels for title VI, part A range 

from $73,620 to $179,810. Current 

funding levels for title VI, part C range 

from $16,990 to $67,990. Distribution of 

funds among tribal organizations is 

subject to the availability of 

appropriations to carry out title VI. 

Funding is based on the number of 

eligible elders over the age of 60 in your 

proposed service area. Successful 

applications from new grantees will be 

funded pending availability of 

additional funds. For those applying for 

title VI, part A funding you have the 

option to also apply for part C. 

However, to apply for part C you must 

apply for both part A and part C.

Legislative authority: The Older 

Americans Act, Public Law 106–501 (Catalog 

of Federal Domestic Assistance 93.047, title 

VI).

Purpose of grant awards: The purpose 

of these grants is to provide nutritional 

and supportive services to Indian elders 

under part A and Family Caregiver 

support services under part C. The goal 

of these programs is to increase home 

and community based services to older 

Indians and Alaska Natives, which 

respond to local needs and are 

consistent with evidence-based 

prevention practices. 

Eligibility for grant awards and other 

requirements: Eligible applicants are all 

current title VI, part A grantees, current 

grantees who wish to leave a consortium 

and apply as a new grantee, and eligible 

federally recognized Indian tribal 

organizations that are not now 

participating in title VI, and would like 

to apply as a new grantee. A tribal 

organization or Indian tribe must meet 

the application requirements contained 

in sections 612(a), 612(b), and 612(c) of 

the OAA. Under the Native American 

Caregiver Support Program a tribal 

organization must meet the 

requirements as contained in section 

631 of the OAA. These sections are 

described in the application kit. 

Executive Order 12372 is not 

applicable to these grant applications. 

Screening criteria: All applicants 

must be Federally Recognized Indian 

tribal organizations representing at least 

50 persons aged 60 years or over. 

Applicants must apply for title VI, part 

A to be eligible to apply for title VI, part 

C.

DATES: The deadline date for the 

submission of applications is January 

31, 2005.

ADDRESSES: Application kits are 

available by writing to the U.S. 

Department of Health and Human 

Services, Administration on Aging, 

Office for American Indian, Alaskan 

Native and Native Hawaiian Programs, 

Washington, DC 20201, by calling (202) 

357–3537 or online at http://

www.aoa.gov. An application kit will be 

mailed to all current grantees. 

Applications may be mailed to the 

U.S. Department of Health and Human 

Services, Administration on Aging, 

Office of Grants Management, 

Washington, DC 20201, attn: Margaret 

Tolson (AoA–04–09). 

Applications may be delivered to the 

U.S. Department of Health and Human 

Services, Administration on Aging, 

Office of Grants Management, One 

Massachusetts Avenue, NW., Room 

4604, Washington, DC 20001, attn: 

Margaret Tolson (AoA–04–09). 

If you elect to mail or hand deliver 

your application you must submit one 

original and two copies of the 

application.

SUPPLEMENTARY INFORMATION: All grant 

applicants must obtain a D–U–N–S 

number from Dun and Bradstreet. It is 

a nine-digit identification number, 

which provides unique identifiers of 

single business entities. The D–U–N–S 

number is free and easy to obtain from 

http://www.dnb.com/US/duns_update/.

Applicants must specify at the 

beginning of the application if you are 

applying for part A funding only or for 

both part A and part C. The application 

must include an appropriate narrative 

description of the geographical area to 

be served. All certifications and 

assurances must be signed and 

submitted with the application as well 

as an original copy of the Tribal council 

resolution authorizing participation in 

title VI, part A or title VI, part A and 

part C for the grant period April 1, 2005, 

to March 31, 2008. If a tribal 

organization represents a consortium of 

more than one Tribe, a resolution is 

required from each participating Tribe, 

specifically authorizing representation 

by the tribal organization for the 

purpose of title VI of the OAA for the 

grant period April 1, 2005, to March 31, 

2008. Applications must identify both 

the principal official of the tribal 

organization, and the proposed title VI 

Program Director. If the applicant tribal 

organization is a consortium the 

applicant must list the federally 

recognized tribes that are included.

FOR FURTHER INFORMATION CONTACT: M. 

Yvonne Jackson, Ph.D.; Office for 

American Indian, Alaskan Native, and 

Native Hawaiian Programs; AoA; 

Department of Health and Human 

Services; Washington, DC 20201; 

telephone (202) 357–3501; fax (202) 

357–3560; e-mail: 

Yvonne.Jackson@aoa.gov.

Dated: October 28, 2004. 

Josefina G. Carbonell, 

Assistant Secretary for Aging.

[FR Doc. 04–24392 Filed 11–1–04; 8:45 am] 

BILLING CODE 4154–01–P

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30Day–04–0307] 

Proposed Data Collections Submitted 

for Public Comment and 

Recommendations 

The Centers for Disease Control and 

Prevention (CDC) publishes a list of 

information collection requests under 

review by the Office of Management and 

Budget (OMB) in compliance with the 

Paperwork Reduction Act (44 U.S.C. 

Chapter 35). To request a copy of these 

requests, call the CDC Reports Clearance 

Officer at (404) 498–1210 or send an email to omb@cdc.gov. Send written 

comments to CDC Desk Officer, Human 

Resources and Housing Branch, New 

Executive Office Building, Room 10235, 

Washington, DC 20503 or by fax to (202) 

395–6974. Written comments should be 

received within 30 days of this notice. 

Proposed Project 

Gonococcal Isolate Surveillance 

Project (GISP), OMB No. 0920–0307—

Revision—National Center for HIV, 

STD, and TB Prevention (NCHSTP), 

Centers for Disease Control and 

Prevention (CDC). 

CDC is requesting a 3-year approval/

with change for this project. The 

objectives of GISP are to monitor trends 

in antimicrobial susceptibility of strains 

of Neisseria gonorrhoeae in the U.S. and 

characterize resistant isolates. GISP 

provides critical surveillance for 

antimicrobial resistance, allowing for 

informed treatment recommendations. 

This project began in 1986 as a 

voluntary surveillance project and has 

involved 5 regional laboratories and 30 

publicly-funded, sexually transmitted 

disease (STD) clinics around the 

country. The STD clinics submit up to 

25 gonococcal isolates per month to the 

regional laboratories, which measure 

susceptibility to a panel of antibiotics. 

Limited demographic and clinical 

Federal Register / Vol. 69, No. 211 / Tuesday, November 2, 2004 / Notices 63541

information corresponding to the 

isolates are submitted directly by the 

STD clinics to CDC. 

During 1986–2003, GISP 

demonstrated the ability to effectively 

achieve its objectives. The emergence, 

in the U.S., of resistance to 

fluoroquinolones, commonly used 

therapies for gonorrhea, was identified 

through GISP and makes ongoing 

surveillance critical. Emergence of 

decreased susceptibility to 

fluoroquinolones among the men having 

sex with men (MSM) population in the 

U.S. was also identified through GISP in 

2003. Data gathered through GISP were 

used to change the treatment for 

gonorrhea for the MSM population in 

April 2004. There are no costs to 

respondents other than their time. The 

estimated annualized burden for this 

data collection is 8,142 hours.

Respondent Number of

respondents 

Number of

responses 

per respondent 

Average

burden per

response

(in hours) 

Laboratory: 

Form 2 ........................................................................................................................................ 5 1368 1

Form 3 ........................................................................................................................................ 5 48 12/60

Clinical personnel .............................................................................................................................. 30 228 11/60

Dated: October 27, 2004. 

B. Kathy Skipper, 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention.

[FR Doc. 04–24385 Filed 11–1–04; 8:45 am] 

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Agency for Toxic Substances and 

Disease Registry 

Public Health Conference Support 

Grant Program 

Announcement Type: New. 

Funding Opportunity Number: 05002. 

Catalog of Federal Domestic 

Assistance Number: The Centers for 

Disease Control and Prevention (CDC) 

Catalog of Federal Domestic Assistance 

(CFDA) number is 93.283. The Agency 

for Toxic Substances and Disease 

Registry (ATSDR) Catalog of Federal 

Domestic Assistance (CFDA) number is 

93.161.

DATES: Key Dates:

Letter of Intent (LOI) Deadline: Cycle 

A: November 24, 2004; Cycle B: 

February 3, 2005. 

Application Deadline: Cycle A: 

January 14, 2005; Cycle B: April 6, 2005. 

I. Funding Opportunity Description

Authority: The Centers for Disease Control 

and Prevention (CDC) program is authorized 

under section 317(k)(2) of the Public Health 

Service Act, [42 U.S.C. 247b(k)(2)] as 

amended. The Agency for Toxic Substances 

and Disease Registry (ATSDR) program is 

authorized under sections 104 (i)(14) and (15) 

of the Comprehensive Environmental 

Response, Compensation, and Liability Act of 

1980 (CERCLA), as amended by the 

Superfund Amendments and Reauthorization 

Act of 1986 (SARA), [42 U.S.C. 9604(i)(14) 

and (15)].

Purpose: The Centers for Disease 

Control and Prevention (CDC) and the 

Agency for Toxic Substances and 

Disease Registry (ATSDR) announce the 

pending availability of appropriated 

fiscal year (FY) 2005 funds for a grant 

program for Public Health Conference 

Support. This program addresses the 

‘‘Healthy People 2010’’ focus areas of 

Disability and Secondary Conditions, 

Educational and Community-Based 

Programs, Environmental Health, Injury 

and Violence Prevention, Maternal, 

Infant and Child Health, Vision and 

Newborn Hearing (specifically newborn 

screening, evaluation and intervention), 

Public Health Infrastructure, 

Tuberculosis, Respiratory Diseases, and 

Sexually Transmitted Diseases (STD). 

Human Immunodeficiency Virus 

(HIV) Conferences and HIV subject 

matter are covered under another 

program and are not permitted under 

this announcement. 

The purpose of conference support 

funding is to provide partial support for 

specific non-Federal conferences (not a 

series) in the areas of health promotion 

and disease prevention information and 

education programs, and applied 

research. A series is the exact same 

conference conducted more than one 

time during the project period. An 

applicant can apply for funding for 

more than one different conference 

during the project period. 

Congress has required that there will 

be active participation by CDC/ATSDR 

in the development and approval of the 

conference agenda to make sure there 

are no subjects that would embarrass the 

Government or be an improper use of 

funds including portions that are not 

funded by CDC/ATSDR. CDC/ATSDR 

funds will be expended only for 

approved portions of the conference. 

The mission of CDC is to promote 

health and improve the quality of life by 

preventing and controlling disease, 

injury, and disability. 

Through the support of conferences 

and meetings (not a series) in the areas 

of public health research, education, 

prevention research in program and 

policy development in managed care 

and prevention application, CDC is 

meeting its overall goal of dissemination 

and implementation of new costeffective intervention strategies. 

The mission of ATSDR is to prevent 

both exposure and adverse human 

health effects that diminish the quality 

of life associated with exposure to 

hazardous substances from waste sites, 

unplanned releases, and other sources 

of pollution present in the environment. 

ATSDR’s systematic approaches are 

needed for linking applicable resources 

in public health with individuals and 

organizations involved in the practice of 

applying such research. Mechanisms are 

also needed to shorten the time frame 

between the development of disease 

prevention and health promotion 

techniques and their practical 

application. ATSDR believes that 

conferences and similar meetings (not a 

series) that permit individuals to engage 

in hazardous substances and 

environmental health research, 

education, and application (related to 

actual and/or potential human exposure 

to toxic substances) to interact, are 

critical for the development and 

implementation of effective programs to 

prevent adverse health effects from 

hazardous substances.

Measurable outcomes of the program 

will be in alignment with one (or more) 

of the following performance goal(s): 

Agency for Toxic Substances and 

Disease Registry (ATSDR): 

• Prevent ongoing and future 

exposures and resultant health effects 

from hazardous waste sites and releases;